News

The company expects to commence the construction by the end of this year. The new plant will feature research, development, and technical service resources In addition to catalyst

Cevira delivers a light-activated treatment known as photodynamic therapy to destroy tissue infections caused by HPV and treat precancerous lesions on the cervix without affecting healthy tissue. Cevira

Anavex will evaluate the safety, maximally tolerated dose, pharmacokinetics and pharmacodynamics in the Phase I trial. Anavex-2-73 represents a new class of wholly owned compounds that act through

HinsBet showed identical results compared to the Novo Nordisk‘s products giving local tolerance and absence of pain at the injection site. The inter-patient variability on glycemic control with

Gerresheimer Medical Plastic Systems, a business unit of the Plastic Systems division, produces insulin pens for diabetics, inhalers, skin-prick aids and disposable laboratory articles for pharma, diagnostics and

The Phase III clinical programme include two 12-week randomized, placebo-controlled efficacy studies (with approximately 630 randomized patients each) and an open-label, randomized, long-term safety study with a ‘usual

Under the terms of the agreement, Novartis will receive exclusive rights to an undisclosed family of oncology compounds discovered and owned by Nerviano. Novartis will have responsibility to

Earlier in January 2011, Plexxikon has started patient recruitment in first of two Phase 1 clinical trials with PLX5622. The initial Phase 1 trial is a single-ascending dose

Nanopore-specific data analysis pipelines for Pipeline Pilot will be offered as the preferred and supported solution for secondary and higher level data analysis for the Oxford Nanopore DNA